Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Minority Interest (2021 - 2025)

Historic Minority Interest for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $705.0 million.

  • Roivant Sciences' Minority Interest rose 10345.54% to $705.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $705.0 million, marking a year-over-year increase of 10345.54%. This contributed to the annual value of $499.6 million for FY2025, which is 409.32% up from last year.
  • As of Q4 2025, Roivant Sciences' Minority Interest stood at $705.0 million, which was up 10345.54% from $443.1 million recorded in Q3 2025.
  • Roivant Sciences' 5-year Minority Interest high stood at $705.0 million for Q4 2025, and its period low was $234.2 million during Q2 2021.
  • Moreover, its 5-year median value for Minority Interest was $425.2 million (2023), whereas its average is $420.1 million.
  • In the last 5 years, Roivant Sciences' Minority Interest plummeted by 2997.48% in 2024 and then surged by 10345.54% in 2025.
  • Quarter analysis of 5 years shows Roivant Sciences' Minority Interest stood at $381.5 million in 2021, then grew by 23.61% to $471.6 million in 2022, then grew by 4.92% to $494.8 million in 2023, then fell by 29.97% to $346.5 million in 2024, then soared by 103.46% to $705.0 million in 2025.
  • Its Minority Interest was $705.0 million in Q4 2025, compared to $443.1 million in Q3 2025 and $470.3 million in Q2 2025.